As an industry leader in respiratory care we know that behind every patient is a story. A family. A struggle. And usually a healthcare team supporting that journey. These challenges inspire us to help professionals working in respiratory to empower their patients with their own care. Our goal is to support healthcare professionals and patients through the highs and lows of life with respiratory disease.
Let’s Talk Respiratory, is an established respiratory content platform with content and input from leading respiratory specialists from across Europe. It welcomes professionals from around the world and has received more than 27,000 HCPs visit the site from more than 150 countries.
This educational initiative, provides up-to-date information to help HCPs to keep on top of what’s happening across respiratory, to support and encourage the clinical outcomes, making a real difference to the lives of those living with asthma and COPD. What makes Let’s Talk Respiratory unique is that it brings together content into a single knowledge hub of expert opinion, news, tips and tools.
And for patients? We know that living with a chronic condition effects a patients lives in so many different ways and it’s why we created Life Effects, an online resource of information and stories for patients by patients.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global leader in generic medicines, with innovative treatments in select areas, including CNS, pain and respiratory. We deliver high-quality generic products and medicines in nearly every therapeutic area to address unmet patient needs. We have an established presence in generics, specialty, OTC and API, building on more than a century-old legacy, with a fully integrated R&D function, strong operational base and global infrastructure and scale. We strive to act in a socially and environmentally responsible way. Headquartered in Israel, with production and research facilities around the globe, we employ 45,000 professionals, committed to improving the lives of millions of patients
Learn more at www.tevapharm.com